These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37353867)

  • 21. Loss to follow-up and mortality among HIV-infected people co-infected with TB at ART initiation in Durban, South Africa.
    Bassett IV; Chetty S; Wang B; Mazibuko M; Giddy J; Lu Z; Walensky RP; Freedberg KA; Losina E
    J Acquir Immune Defic Syndr; 2012 Jan; 59(1):25-30. PubMed ID: 22027877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tuberculosis treatment outcome and predictors in northern Ethiopian prisons: a five-year retrospective analysis.
    Adane K; Spigt M; Dinant GJ
    BMC Pulm Med; 2018 Feb; 18(1):37. PubMed ID: 29463234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient and healthcare delays in critical and non-critical pulmonary tuberculosis incidence areas in Portugal: are there differences?
    Almeida Santos J; Soares P; Leite A; Duarte R; Nunes C
    Public Health; 2021 Dec; 201():41-47. PubMed ID: 34742116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Competing risk of mortality on loss to follow-up outcome among patients with HIV on ART: a retrospective cohort study from the Zimbabwe national ART programme.
    Matsena Zingoni Z; Chirwa T; Todd J; Musenge E
    BMJ Open; 2020 Oct; 10(10):e036136. PubMed ID: 33028546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nearly one in every six HIV-infected children lost from ART follow-up at Debre Markos Referral Hospital, Northwest Ethiopia: A 14-year retrospective follow-up study.
    Hibstie YT; Kibret GD; Talie A; Temesgen B; Melkamu MW; Alebel A
    PLoS One; 2020; 15(9):e0239013. PubMed ID: 32931502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss to follow-up and associated maternal factors among HIV-exposed infants at the Mbarara Regional Referral Hospital, Uganda: a retrospective study.
    Ankunda R; Cumber SN; Atuhaire C; Kabanda T; Nkfusai CN; Wirsiy FS; Turyakira E
    BMC Infect Dis; 2020 Mar; 20(1):235. PubMed ID: 32192458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What happened to patients with RMP-resistant/MDR-TB in Zambia reported as lost to follow-up from 2011 to 2014?
    Kasapo CC; Chimzizi R; Simwanza SC; Mzyece J; Chizema E; Mariandyshev A; Lee HY; Harries AD; Kapata N
    Int J Tuberc Lung Dis; 2017 Aug; 21(8):887-893. PubMed ID: 28786797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss to follow-up of patients in HIV care in Burundi: A retrospective cohort study.
    Nshimirimana C; Ndayizeye A; Smekens T; Vuylsteke B
    Trop Med Int Health; 2022 Jun; 27(6):574-582. PubMed ID: 35411666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low BMI increases all-cause mortality rates in patients with drug-resistant TB.
    Adamashvili N; Baliashvili D; Kuchukhidze G; Salindri AD; Kempker RR; Blumberg HM; Lomtadze N; Avaliani Z; Magee MJ
    Int J Tuberc Lung Dis; 2022 Apr; 26(4):326-333. PubMed ID: 35351237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of the observed high prevalence of loss to follow-up in ART-experienced adult PLHIV: a retrospective longitudinal cohort study in the Tanga Region, Tanzania.
    Mushy SE; Mtisi E; Mboggo E; Mkawe S; Yahya-Malima KI; Ndega J; Ngalesoni F; Muya A
    BMC Infect Dis; 2023 Feb; 23(1):92. PubMed ID: 36788523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003-2015).
    Mutanga JN; Mutembo S; Ezeamama AE; Song X; Fubisha RC; Mutesu-Kapembwa K; Sialondwe D; Simuchembu B; Chinyonga J; Thuma PE; Whalen CC
    BMC Public Health; 2019 Aug; 19(1):1120. PubMed ID: 31416432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A combination of quantitative and qualitative methods in investigating risk factors for lost to follow-up for tuberculosis treatment in Japan - Are physicians and nurses at a particular risk?
    Kawatsu L; Uchimura K; Ohkado A; Kato S
    PLoS One; 2018; 13(6):e0198075. PubMed ID: 29906287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hidden loss to follow-up among tuberculosis patients managed by public-private mix institutions in South Korea.
    Kim HW; Park S; Min J; Sun J; Shin AY; Ha JH; Park JS; Lee SS; Lipman M; Abubakar I; Stagg HR; Kim JS
    Sci Rep; 2022 Jul; 12(1):12362. PubMed ID: 35859107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Loss to follow-up in patients treated for multidrug-resistant tuberculosis in EcuadorA Perda de seguimento de pacientes tratados para tuberculose multirresistente a medicamentos no Equador].
    Tatés-Ortega N; Álvarez J; López L; Mendoza-Ticona A; Alarcón-Arrascue E
    Rev Panam Salud Publica; 2019; 43():e91. PubMed ID: 31892925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Same-day antiretroviral therapy is associated with increased loss to follow-up in South African public health facilities: a prospective cohort study of patients diagnosed with HIV.
    Joseph Davey D; Kehoe K; Serrao C; Prins M; Mkhize N; Hlophe K; Sejake S; Malone T
    J Int AIDS Soc; 2020 Jun; 23(6):e25529. PubMed ID: 32510186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective assessment of loss to follow-up: incidence and associated factors in a cohort of HIV-positive adults in rural Tanzania.
    Kalinjuma AV; Glass TR; Weisser M; Myeya SJ; Kasuga B; Kisung'a Y; Sikalengo G; Katende A; Battegay M; Vanobberghen F;
    J Int AIDS Soc; 2020 Mar; 23(3):e25460. PubMed ID: 32128998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss to follow-up and associated factors among adult people living with HIV at public health facilities in Wakiso district, Uganda: a retrospective cohort study.
    Opio D; Semitala FC; Kakeeto A; Sendaula E; Okimat P; Nakafeero B; Nankabirwa JI; Karamagi C; Kalyango JN
    BMC Health Serv Res; 2019 Sep; 19(1):628. PubMed ID: 31484571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
    Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
    PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nationwide analysis of treatment outcomes in children and adolescents routinely treated for tuberculosis in the Netherlands.
    Gafar F; Van't Boveneind-Vrubleuskaya N; Akkerman OW; Wilffert B; Alffenaar JC
    Eur Respir J; 2019 Dec; 54(6):. PubMed ID: 31515410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isoniazid mono-resistant tuberculosis: Time to take it seriously.
    Garg K; Saini V; Dhillon R; Agarwal P
    Indian J Tuberc; 2019 Apr; 66(2):247-252. PubMed ID: 31151492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.